可穿戴设备在糖尿病患者血糖管理中的应用价值分析

目的 探讨可穿戴设备在糖尿病患者血糖管理中的应用价值。方法 选取2017年6月～2018年6月我院收治的2型糖尿病患者随机分为观察组和对照组(60例/组),入院后第2天对照组患者的指尖血糖监测采用血糖仪,观察组采用动态血糖监测系统进行血糖实时监测,并佩戴胰岛素泵,两组患者均根据监测结果适当调整胰岛素泵的输注剂量,两组均治疗2周,治疗最后1 d均采用动态血糖监测系统进行血糖监测,观察两组患者血糖达标用时、胰岛素用量、空腹血糖,治疗前、治疗2周后两组24 h平均血糖值(MBG)及其标准差(SD)、CGMS参数,血糖曲线下面积(AUC)、日内血糖平均漂移幅度(MAGE)、日内血糖平均绝对差(MODD)及治疗2周的空腹血糖、早、中、晚餐后2 h血糖。结果 治疗后两组MBG、SD、AUC、MAGE、MODD、两组空腹、早、中、晚餐后2 h血糖及睡前血糖均显著下降(P0.05),但观察组下降更为明显(均P0.05)。对照组的血糖达标用时、胰岛素用量均显著高于观察组(均P0.05)。结论 CGMS监测2型糖尿病患者血糖可有效控制空腹血糖及餐后血糖,缩短血糖达标时间,减少胰岛素用量。

Analysis on the application value of wearable devices in blood glucose management of diabetic patients

Objective To explore the application value of wearable devices in blood glucose management in diabetic patients.Methods Patients with type 2 diabetes who were admitted to our hospital from June 2017 to June 2018 were selected and randomly divided into observation group and control group(60 cases/group).On the second day after admission,the glucometer was used for fingertip blood glucose monitoring in the control group.The observation group was given a dynamic blood glucose monitoring system to monitor blood glucose in a real time and wear an insulin pump.Both groups of patients adjusted the infusion dose of the insulin pump according to the monitoring results.Both groups were treated for 2 weeks.On the last day of treatment,blood glucose was monitored using a dynamic blood glucose monitoring system.The duration of blood glucose standardization,insulin dosage,fasting blood glucose,the mean blood glucose(MBG) and its standard deviation(SD) before treatment and 2 weeks after treatment,CGMS parameters,area under the curve(AUC) of blood glucose,intraday mean amplitude of glycemic excursions(MAGE),intraday mean of daily difference(MODD) of blood glucose,the fasting blood glucose 2 weeks after treatment,and 2 h blood glucose after breakfast,lunch and dinner were observed in both groups.Results After treatment,the MBG,SD,AUC,MAGE,MODD,fasting blood glucose,blood glucose levels 2 h after breakfast,meal and dinner and bedtime blood glucose were significantly decreased in both groups(P<0.05).However,the decrease in the observation group was more obvious(both P<0.05).In the control group,the duration of blood glucose standardization and insulin dosage were significantly higher than those in the observation group(both P<0.05).Conclusion CGMS monitoring blood glucose in patients with type 2 diabetes can effectively control fasting and postprandial blood glucose,shorten the duration of blood glucose standardization,and reduce insulin dosage.